Conservative management of postpartum hemorrhage  by Karaman, Erbil et al.
lable at ScienceDirect
Taiwanese Journal of Obstetrics & Gynecology 54 (2015) 801e802Contents lists avaiTaiwanese Journal of Obstetrics & Gynecology
journal homepage: www.t jog-onl ine.comCorrespondenceConservative management of postpartum hemorrhageDear Editor,
We appreciate Dr Wang's advice on our previous study [1] and
his valuable review on this important topic. Dr Wang has pointed
out several important issues, and we would like to respond and
further discuss here.
First of all, our study included 47 cases of pregnant womenwho
had postpartum hemorrhage (PPH), intractable to conservative
medical management. The majority of our patients underwent ce-
sarean section (CS), and some of them had high risk for PPH. As per
our hospital's policy, the preoperative strategy for high-risk pa-
tients includes the preparation of adequate blood-transfusion prod-
ucts and the availability of at least one senior consultant
obstetrician who is able to manage PPH. Two recent articles have
shown the effectiveness of uterine-vessel embolization; however,
we think that predelivery embolization is not a good alternative
to CS in the case of a pregnant woman with a healthy third-
trimester pregnancywith placenta previa [2,3]. Similarly, the article
by Huang et al [2] showed its effectiveness in the termination of
pregnancy with placenta previa due to fetal death and serious fetal
malformations at 22e29 weeks, or persistent vaginal bleeding at
21e22 weeks of pregnancy before viability. Therefore, it is obvious
that predelivery embolization cannot be accepted for the pregnant
woman who has a healthy third-trimester pregnancy. Also, our
institution has no resources for embolization, and so we have no
strategy for that kind of treatment. Nonetheless, we think that it
can be a good alternative to CS in the case of pregnancy termination
before viability, as stated by Huang et al [2]. In addition, iliac or
uterine-artery ligation might also be considered in patients with
PPH. However, these techniques need some surgical skills, espe-
cially for internal iliac-artery ligation, and also cause concern for
some complications. In our study, the intraoperative strategy
when dealingwith PPH, either due to the uterine atony or abnormal
placentation, included ﬁrstly the medical conservative treatment
(uterine massage, uterotonics, and bimanual compression), and
then applying the Bakri balloon tamponade (BBT). If the bleeding
did not stop, the invasive procedure, including vessel ligation or
uterine compression sutures, was performed, and if this failed
ﬁnally, hysterectomy was performed. We agree with the report by
Liu et al [4], and it seems rational to ligate the uterine artery in
pregnant women with uterine leiomyomas, who are undergoing
CS. Importantly, it should be suggested to perform ligation to the
uterine artery (right or left) that provides the blood supply to the
leiomyoma.
Secondly, BBT should be appliedwhenmedical treatment fails to
stop bleeding during delivery, either vaginal or CS, after exclusionhttp://dx.doi.org/10.1016/j.tjog.2015.10.021
1028-4559/Copyright © 2015, Taiwan Association of Obstetrics & Gynecology. Publishedof genital lacerations. This is the ideal time to perform BBT. We
could not give the time interval between the occurrence of PPH
and the insertion of BBT as the data from medical records were
not available. However, consistent with our experience, we can
say that it is more efﬁcient to use BBT in CS than in vaginal delivery
because more time is spent on follow-up after a vaginal delivery.
PPH was deﬁned as >500 mL estimated blood loss after a vaginal
delivery, or >1000 mL after a CS. In our study, the blood loss was
calculated by blood volume after delivery (PPH), including the
intraoperative blood loss during CS or vaginal delivery, as presented
in Table 1 [1].
Thirdly, the strategy before the insertion of BBT differs in
different types of PPH. We suggest performing multiple placental
bed sutures in order to stop or minimize the bleeding in the case
of PPH due to abnormal placentation, and then applying the BBT.
However, in the case of uterine atony, we suggest the medical treat-
ments, including uterotonics and uterine massage, either during CS
or vaginal delivery, after exclusion of retained placental products or
genital lacerations, and then if these failed, the BBT should be
applied without delay. In our experience, it is crucial to protect pa-
tients from disseminated intravascular coagulation during an
attempt to stop bleeding. If disseminated intravascular coagulation
develops, it will be too late to apply BBT.
Fourthly, our study was a retrospective study, and so we could
not measure the exact time that passed from failure of attempt to
stopping the bleeding to using BBT. Similarly, when analyzing the
literature, we could not ﬁnd any data regarding the median time
between the failure of attempt to stop bleeding and the use of
BBT [5,6]. This might be caused by the emergency feature of
PPH and the record of the time cannot be held. Therefore, we think
that the delay in time to perform BBT differs between CS and
vaginal delivery. Physicians tend to wait and monitor the bleeding
during and after a medical conservative treatment, and this leads
to spending more time in vaginal delivery. However, during CS,
obstetricians are aware of the bleeding, and it is reasonable that
the procedures are initiated more promptly than during vaginal
delivery.
Finally, we appreciate the suggestions and comments from Dr
Wang, and we accept the opinion that an earlier application of
effective tools and the availability of a well-trained team might
be the best chance to preserve fertility in patients with PPH.Conﬂicts of interest
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